Modulation of glucocorticoid receptor expression

Details for Australian Patent Application No. 2006292293 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors McKay, Robert; Monia, Brett P.; Watts, Lynnetta; Freier, Susan M.; Bhanot, Sanjay

Agent Pizzeys

Pub. Number AU-B-2006292293

PCT Pub. Number WO2007/035759

Priority 60/718,685 19.09.05 US

Filing date 19 September 2006

Wipo publication date 29 March 2007

Acceptance publication date 13 September 2012

International Classifications

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61P 3/00 Drugs for disorders of the metabolism

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 38/00 Medicinal preparations containing peptides

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/035759 Priority application(s): WO2007/035759

22 July 2010 Assignment before Grant

  Johnson & Johnson Pharmaceutical Research & Development L.L.C. The application has been assigned to Isis Pharmaceuticals, Inc.

13 September 2012 Application Accepted

  Published as AU-B-2006292293

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292299-Productivity suite to line of business synchronization mechanism

2006292286-Low acrylamide foods